Preoperative platelet-albumin–bilirubin grades predict the prognosis of patients with hepatitis B virus-related hepatocellular carcinoma after liver resection

What is it about?

Minimal information is available concerning platelet-albumin–bilirubin (PALBI) grades in patients with hepatocellular carcinoma (HCC) following liver resection. This study aimed to investigate the predictive ability of PALBI grades in patients with a Child–Pugh class A score and hepatitis B virus-related (HBV-related) HCC after liver resection.

Featured Image

Photo by Robina Weermeijer on Unsplash

Photo by Robina Weermeijer on Unsplash

Why is it important?

Recently, based on the ALBI grade, the platelet-albumin–bilirubin (PALBI) grade was developed to assess a patient's liver function. This grade incorporates blood platelet count as a surrogate maker of portal hypertension. Both ALBI and PALBI include only objective factors. Despite some external validations of the ALBI and PALBI grades, whether the PALBI score could predict a HCC patient's outcome after liver resection remains unclear.In this study, we attempted to clarify this issue.

Perspectives

“

Our study confirmed that the PALBI grade, an objective and evidence-based tool, is a surrogate marker for the prognosis in patients with HCC following liver resection.

”